Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplaque Efficacy of CHX, CPC, and EO Mouthwashes in Orthodontic Patients
NCT07490873Completed
- Sponsor
- University of Baghdad
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Conventional Liposomes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of chlorhexidine + cymenol gel and cetylpyridinium chloride in dental plaque and gingivitis (4 arms), sponsored by University of Baghdad. Primary endpoints: Plaque index at 10 weeks, Gingival index at 10 weeks and 1 more. Started Jan 2026; status: completed.
02
Drugs
chlorhexidine + cymenol gelcetylpyridinium chloride
03
Conditions
dental plaquegingivitis
Beyond the preview
Go deeper on NCT07490873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07490873.